Blacksmith Medicines and Zoetis collaborate for novel animal health antibiotics
Through our research, we aim to ultimately provide new options for our customers to treat life-threatening infections in livestock
Through our research, we aim to ultimately provide new options for our customers to treat life-threatening infections in livestock
Global TB incidence saw a reduction of 8.7% while in India we were able to demonstrate a reduction of 16%, almost double the pace
Exblifeb demonstrates remarkable efficacy in treating complicated Urinary Tract Infections (cUTI), pneumonia
This agreement includes upfront and milestone payments with a combined potential value of over $500m and sales royalties.
Innovent will supply sintilimab for the collaborated clinical trial
The findings of Phase 3 study are in line with Phase 2 study conducted in the US and Europe
Conditional marketing authorization is based on clinically meaningful response rates, duration of response, and safety from the Phase 2 MagnetisMM-3 trial
First-in-class AKT inhibitor has potential to reshape treatment for breast cancer patients
Emphasizes the need for a collective effort on bolstering resilience across economies, societies, healthcare systems, education systems and infrastructure
Subscribe To Our Newsletter & Stay Updated